Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Hims & Hers will stop selling compound GLP-1 drugs under a lawsuit settlement, ending their telehealth availability.
Hims & Hers Health will discontinue selling compound GLP-1 medications as part of a settlement in a lawsuit, according to a court filing.
The company did not admit wrongdoing but agreed to the terms to resolve allegations related to the marketing and distribution of the drugs.
The move affects its telehealth offerings and comes amid increased scrutiny of weight-loss and diabetes treatments sold online.
23 Articles
Hims & Hers dejará de vender fármacos compuestos GLP-1 en virtud de un acuerdo judicial, poniendo fin a su disponibilidad de telesalud.